Cargando…
Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy. Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not without risks to the patient. Therefore, it is important that permanent cures for HIV infection are developed. T...
Autor principal: | Freen-van Heeren, Julian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326690/ https://www.ncbi.nlm.nih.gov/pubmed/35892930 http://dx.doi.org/10.3390/biotech11030025 |
Ejemplares similares
-
Using CRISPR to enhance T cell effector function for therapeutic applications
por: Freen-van Heeren, Julian J.
Publicado: (2020) -
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection
por: Liu, Zhepeng, et al.
Publicado: (2017) -
HIV Transmission: Closing All the Doors
por: Davis, Carl W., et al.
Publicado: (2004) -
The Closed Door
Publicado: (1905) -
CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
por: Grande, Fedora, et al.
Publicado: (2019)